GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nippon Shinyaku Co Ltd (OTCPK:NPPNY) » Definitions » Total Liabilities

NPPNY (Nippon Shinyaku Co) Total Liabilities : $233 Mil (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Nippon Shinyaku Co Total Liabilities?

Nippon Shinyaku Co's Total Liabilities for the quarter that ended in Sep. 2024 was $233 Mil.

Nippon Shinyaku Co's quarterly Total Liabilities declined from Mar. 2024 ($286.15 Mil) to Jun. 2024 ($0.00 Mil) but then increased from Jun. 2024 ($0.00 Mil) to Sep. 2024 ($232.89 Mil).

Nippon Shinyaku Co's annual Total Liabilities declined from Mar. 2022 ($329.40 Mil) to Mar. 2023 ($310.63 Mil) and declined from Mar. 2023 ($310.63 Mil) to Mar. 2024 ($286.15 Mil).


Nippon Shinyaku Co Total Liabilities Historical Data

The historical data trend for Nippon Shinyaku Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nippon Shinyaku Co Total Liabilities Chart

Nippon Shinyaku Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 322.04 386.37 329.40 310.63 286.15

Nippon Shinyaku Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 255.17 225.82 286.15 - 232.89

Nippon Shinyaku Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Nippon Shinyaku Co's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=249.208+(7.689+1.949
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+27.3)
=286

Total Liabilities=Total Assets (A: Mar. 2024 )-Total Equity (A: Mar. 2024 )
=1758.153-1472.007
=286

Nippon Shinyaku Co's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=193.853+(8.632+2.07
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+28.331)
=233

Total Liabilities=Total Assets (Q: Sep. 2024 )-Total Equity (Q: Sep. 2024 )
=1878.52-1645.634
=233

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nippon Shinyaku Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Nippon Shinyaku Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Nippon Shinyaku Co Business Description

Traded in Other Exchanges
Address
14, Nishinosho-Monguchi-cho, Kisshoin, Minami-ku, Kyoto, JPN, 601-8550
Nippon Shinyaku Co Ltd is a specialty and generic drug manufacturing company. Nippon's research and development activities include a focus on pharmaceuticals, nutraceuticals, safety and pharmacokinetics of drug seeds, genomic drug discovery, and nucleic acid drugs. The company also develops health food ingredients, preservatives, protein preparations, and spices. Nippon considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Nippon Shinyaku Co Headlines

No Headlines